Pharmaceutical

Jaguar Health Secures New Patent for Crofelemer in Short Bowel Syndrome, Strengthening Global IP Position Ahead of Additional Clinical Milestones

This new IP supports crofelemer's global exclusivity in rare pediatric intestinal failure coincident with published clinical data showing reductions in…

3 weeks ago

Main Line Psychiatric Practice Expands Comprehensive Mental Health Care for Autism and ADHD

Psychiatric Associates of Pennsylvania Addresses Critical Gap in Neurodevelopmental Mental Health Services NARBERTH, PA / ACCESS Newswire / November 24,…

3 weeks ago

Main Line Psychiatric Practice Expands Comprehensive Mental Health Care for Autism and ADHD

Psychiatric Associates of Pennsylvania Addresses Critical Gap in Neurodevelopmental Mental Health Services NARBERTH, PA / ACCESS Newswire / November 24,…

3 weeks ago

AI/ML Subsidiary Neural Cloud Begins Pilot at SickKids to Advance AI-Enabled Pediatric Cardiac Care

Pilot Project to Explore AI-Driven ECG Signal Processing and Predictive Deterioration Models in Pediatric Cardiac Care TORONTO, ON / ACCESS…

3 weeks ago

AI/ML Subsidiary Neural Cloud Begins Pilot at SickKids to Advance AI-Enabled Pediatric Cardiac Care

Pilot Project to Explore AI-Driven ECG Signal Processing and Predictive Deterioration Models in Pediatric Cardiac Care TORONTO, ON / ACCESS…

3 weeks ago

CureVac Announces Financial Results for the Third Quarter and First Nine Months of 2025 and Provides Business Updates

German Federal Cartel Office clearance obtained for the planned BioNTech - CureVac transaction announced on June 12, 2025, marking an…

3 weeks ago

Bausch Health Announces Launch of Offers to Exchange Certain Existing Senior Secured Notes

LAVAL, QC / ACCESS Newswire / November 24, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) (the "Company" or "Bausch Health")…

3 weeks ago

OneMedNet to Showcase Transformative New Platform at RSNA 2025

MINNEAPOLIS, Nov. 24, 2025 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD), the curator and provider of the largest global live,…

3 weeks ago

Clearmind Medicine’s Data and Safety Monitoring Board Unanimously Approves Continuation of Phase I/IIa Clinical Trial for CMND-100 Following Positive Interim Safety Review

Vancouver, Canada, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a…

3 weeks ago

Gelteq Announces Positive Preclinical Results Demonstrating Enhanced Bioavailability Using Its Proprietary Gel-Based Drug Delivery Platform

Findings Anticipated to Unlock Broad New Commercial Opportunities Across Water-Soluble Drug ClassesMELBOURNE, Australia, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Gelteq…

3 weeks ago